Alzheimer's drugs appeal victory
The Appeal Court has ruled an NHS advisory body should have been more transparent in the way it made decisions over Alzheimer's drugs. Eisai, which makes Aricept, had challenged the process by which it and similar medicines were restricted to people with late stage disease. Three judges said the advisory body should have released details of how it reached its decision. However, the ruling does not mean the drugs will be more widely available.